HBA names Shire's Sibley Woman of the Year

Share this article:
Shire's Sibley: HBA WOTY
Shire's Sibley: HBA WOTY

At a luncheon May 8, the Healthcare Businesswomen's Association (HBA) awarded Charlotte Sibley Woman of the Year for 2008. Sibley is senior vice president, leadership development, at Shire Pharmaceuticals.

In a speech during the event, held at the Hilton in New York City, Sibley underscored the importance of quality leadership.  "Would you want to work for you?" Sibley asked over 2,000 attendees at the luncheon.  Quoting Maya Angelou, Sibley said, "people will forget what you said, people will forget what you did, but people will never forget how you made them feel." Prior to her position at Shire, Sibley worked for Pharmacia Corporation (now Pfizer), Johnson & Johnson and Bristol-Myers Squibb.

Other awards given at the ceremony included the 2008 Honorable Mentor, to Leonard Kanavy, VP commercial operations at Genentech, and the Star Volunteer award, to Anne Camille Talley, an industry consultant with Health Leaders Consultancy.

Additionally, 95 “Rising Stars,” described as “up-and-coming professionals” in the healthcare industry, were recognized by the HBA at the luncheon.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.